Catherine Harding-Rose

1000 total citations
19 papers, 837 citations indexed

About

Catherine Harding-Rose is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Catherine Harding-Rose has authored 19 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 11 papers in Cellular and Molecular Neuroscience and 8 papers in Pharmacology. Recurrent topics in Catherine Harding-Rose's work include Pain Mechanisms and Treatments (18 papers), Cannabis and Cannabinoid Research (8 papers) and Neuropeptides and Animal Physiology (8 papers). Catherine Harding-Rose is often cited by papers focused on Pain Mechanisms and Treatments (18 papers), Cannabis and Cannabinoid Research (8 papers) and Neuropeptides and Animal Physiology (8 papers). Catherine Harding-Rose collaborates with scholars based in United States, Netherlands and Belgium. Catherine Harding-Rose's co-authors include Donald A. Simone, Virginia S. Seybold, Iryna A. Khasabova, Kenneth Hargreaves, Christopher M. Flores, Sergey G. Khasabov, Sonja Kilo, Yvonne M. Ulrich‐Lai, David M. Cain and Harold E. Goodis and has published in prestigious journals such as Journal of Neuroscience, Brain Research and Pain.

In The Last Decade

Catherine Harding-Rose

19 papers receiving 823 citations

Peers

Catherine Harding-Rose
Iryna A. Khasabova United States
Kara McNair United Kingdom
Brianna Marie Lutz United States
Bethany Fitzsimmons United States
Zhi-Ye Zhuang United States
Jon P. Hatcher United Kingdom
Soon Kwon Park United States
Kwan Yeop Lee United States
Iryna A. Khasabova United States
Catherine Harding-Rose
Citations per year, relative to Catherine Harding-Rose Catherine Harding-Rose (= 1×) peers Iryna A. Khasabova

Countries citing papers authored by Catherine Harding-Rose

Since Specialization
Citations

This map shows the geographic impact of Catherine Harding-Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Harding-Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Harding-Rose more than expected).

Fields of papers citing papers by Catherine Harding-Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Harding-Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Harding-Rose. The network helps show where Catherine Harding-Rose may publish in the future.

Co-authorship network of co-authors of Catherine Harding-Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Harding-Rose. A scholar is included among the top collaborators of Catherine Harding-Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Harding-Rose. Catherine Harding-Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lunzer, Mary M., et al.. (2019). Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5. Neuropharmacology. 160. 107690–107690. 14 indexed citations
2.
Khasabova, Iryna A., et al.. (2013). Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. Neurobiology of Disease. 58. 19–28. 22 indexed citations
3.
Uhelski, Megan L., David M. Cain, Catherine Harding-Rose, & Donald A. Simone. (2013). The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain. Neuroscience. 247. 84–94. 28 indexed citations
4.
Khasabova, Iryna A., et al.. (2012). Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy. Journal of Neuroscience. 32(20). 7091–7101. 94 indexed citations
5.
Khasabova, Iryna A., et al.. (2011). Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. Pharmacological Research. 64(1). 60–67. 66 indexed citations
6.
Bowles, Walter R., et al.. (2011). Sex Differences in Neuropeptide Content and Release from Rat Dental Pulp. Journal of Endodontics. 37(8). 1098–1101. 5 indexed citations
7.
Khasabova, Iryna A., et al.. (2011). CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain. Behavioural Pharmacology. 22(5 and 6). 607–616. 37 indexed citations
8.
Harding-Rose, Catherine, et al.. (2008). The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms. Brain Research. 1215. 69–75. 37 indexed citations
9.
Khasabova, Iryna A., Sergey G. Khasabov, Catherine Harding-Rose, et al.. (2008). A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia in a Model of Bone Cancer Pain. Journal of Neuroscience. 28(44). 11141–11152. 76 indexed citations
10.
Khasabova, Iryna A., Cheryl L. Stucky, Catherine Harding-Rose, et al.. (2007). Chemical Interactions between Fibrosarcoma Cancer Cells and Sensory Neurons Contribute to Cancer Pain. Journal of Neuroscience. 27(38). 10289–10298. 55 indexed citations
11.
Khasabov, Sergey G., Darryl T. Hamamoto, Catherine Harding-Rose, & Donald A. Simone. (2007). Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain. Brain Research. 1180. 7–19. 50 indexed citations
12.
Bowles, Walter R., et al.. (2006). Chronic nerve growth factor administration increases the peripheral exocytotic activity of capsaicin-sensitive cutaneous neurons. Neuroscience Letters. 403(3). 305–308. 18 indexed citations
13.
Gilchrist, Laura, David M. Cain, Catherine Harding-Rose, et al.. (2005). Re-organization of P2X3 receptor localization on epidermal nerve fibers in a murine model of cancer pain. Brain Research. 1044(2). 197–205. 60 indexed citations
14.
Khasabova, Iryna A., Catherine Harding-Rose, Donald A. Simone, & Virginia S. Seybold. (2004). Differential Effects of CB1 and Opioid Agonists on Two Populations of Adult Rat Dorsal Root Ganglion Neurons. Journal of Neuroscience. 24(7). 1744–1753. 68 indexed citations
16.
Ulrich‐Lai, Yvonne M., Christopher M. Flores, Catherine Harding-Rose, Harold E. Goodis, & Kenneth Hargreaves. (2001). Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from rat trigeminal ganglion: evidence for intraganglionic neurotransmission. Pain. 91(3). 219–226. 75 indexed citations
17.
Ulrich‐Lai, Yvonne M., Catherine Harding-Rose, Athena Guo, Walter R. Bowles, & William C. Engeland. (2001). ACTH inhibits the capsaicin-evoked release of CGRP from rat adrenal afferent nerves. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 280(1). R137–R142. 8 indexed citations
18.
Ulrich‐Lai, Yvonne M., Kenneth Hargreaves, Catherine Harding-Rose, Walter R. Bowles, & William C. Engeland. (1998). Characterization of iCGRP release from adrenal capsule primary afferent neurons. Endocrine Research. 24(3-4). 777–778. 1 indexed citations
19.
Kilo, Sonja, Catherine Harding-Rose, Kenneth Hargreaves, & Christopher M. Flores. (1997). Peripheral CGRP release as a marker for neurogenic inflammation: a model system for the study of neuropeptide secretion in rat paw skin. Pain. 73(2). 201–207. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026